Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia
Raffaele Palmieri1,2, Luca Maurillo1, Maria Ilaria Del Principe1
1Department of Biomedicine and Prevention, Tor Vergata University, 00133 Rome, Italy.
Cancers
|January 8, 2023
Abstract:
Informed treatment decision-making in acute myeloid leukemia (AML) requires a comprehensive evaluation of all clinical and biological features that may affect the outcome with any given type or intensity of therapy [...].
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.1K
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
215
